Sign in
4

Changes in Ownership

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-23-007932

VP, Chief Commercial Officer gave up 11,813 shares (to pay taxes)

  • VP, Chief Commercial Officer acquired 43,082 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Seth Kiernan · VP, Chief Commercial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-28 Exercise or conversion : show line 1 in the form +14,833 36,700 D
2023-02-28 Exercise or conversion : show line 2 in the form +5,286 41,986 D
2023-02-28 Exercise or conversion : show line 3 in the form +22,963 64,949 D
2023-02-28 Shares withheld for taxes : show line 4 in the form −11,813 $2.17 $25,634 53,136 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-02-28 Exercise or conversion : show line 5 in the form Restricted Stock Units −14,833 0 D
2023-02-28 Exercise or conversion : show line 6 in the form Restricted Stock Units −5,286 5,287 D
2023-02-28 Exercise or conversion : show line 7 in the form Restricted Stock Units −22,963 45,927 D
Loading xslF345X03/form4.xml…